BR112022012350A2 - Nucleases de spcas9 de alta fidelidade para modificação de genoma - Google Patents

Nucleases de spcas9 de alta fidelidade para modificação de genoma

Info

Publication number
BR112022012350A2
BR112022012350A2 BR112022012350A BR112022012350A BR112022012350A2 BR 112022012350 A2 BR112022012350 A2 BR 112022012350A2 BR 112022012350 A BR112022012350 A BR 112022012350A BR 112022012350 A BR112022012350 A BR 112022012350A BR 112022012350 A2 BR112022012350 A2 BR 112022012350A2
Authority
BR
Brazil
Prior art keywords
genome modification
variants
fidelity
spcas9 nucleases
nucleases
Prior art date
Application number
BR112022012350A
Other languages
English (en)
Inventor
Chen Fuqiang
Original Assignee
Sigma Aldrich Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Aldrich Co Llc filed Critical Sigma Aldrich Co Llc
Publication of BR112022012350A2 publication Critical patent/BR112022012350A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NUCLEASES DE SPCAS9 DE ALTA FIDELIDADE PARA MODIFICAÇÃO DE GENOMA. A presente invenção refere-se a variantes e sistemas de proteína Cas9 manipulada, ácidos nucleicos que codificam as variantes e os sistemas de proteínas referidos, e métodos de produção e uso das variantes e dos sistemas de proteínas referidos para modificação de genoma.
BR112022012350A 2020-03-11 2021-03-11 Nucleases de spcas9 de alta fidelidade para modificação de genoma BR112022012350A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062988279P 2020-03-11 2020-03-11
PCT/US2021/021922 WO2021183771A1 (en) 2020-03-11 2021-03-11 High fidelity spcas9 nucleases for genome modification

Publications (1)

Publication Number Publication Date
BR112022012350A2 true BR112022012350A2 (pt) 2022-09-27

Family

ID=75539896

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022012350A BR112022012350A2 (pt) 2020-03-11 2021-03-11 Nucleases de spcas9 de alta fidelidade para modificação de genoma

Country Status (10)

Country Link
US (1) US20230058352A1 (pt)
EP (1) EP4118197A1 (pt)
JP (1) JP2023514327A (pt)
KR (1) KR20220128644A (pt)
CN (1) CN115244177A (pt)
AU (1) AU2021236230A1 (pt)
BR (1) BR112022012350A2 (pt)
CA (1) CA3163463A1 (pt)
IL (1) IL294120B2 (pt)
WO (1) WO2021183771A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023077149A1 (en) 2021-11-01 2023-05-04 Sigma-Aldrich Co. Llc Electroporation enhancers for crispr-cas systems
CN117866926A (zh) * 2024-03-07 2024-04-12 珠海舒桐医疗科技有限公司 一种CRISPR-FrCas9蛋白突变体及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005010A (es) 2001-11-26 2005-04-08 Advanced Cell Tech Inc METODO PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS METODOS PARA HACER Y USAR NUCLEOS CELULARES SOMáTICOS HUMANOS REPROGRAMADOS Y CELULAS DEL TALLO HUMANAS AUTOLOGAS E ISOGENICAS.
CN109536474A (zh) * 2015-06-18 2019-03-29 布罗德研究所有限公司 降低脱靶效应的crispr酶突变
US11242542B2 (en) * 2016-10-07 2022-02-08 Integrated Dna Technologies, Inc. S. pyogenes Cas9 mutant genes and polypeptides encoded by same

Also Published As

Publication number Publication date
CA3163463A1 (en) 2021-09-16
IL294120B2 (en) 2023-10-01
AU2021236230A1 (en) 2022-06-30
EP4118197A1 (en) 2023-01-18
IL294120B1 (en) 2023-06-01
US20230058352A1 (en) 2023-02-23
CN115244177A (zh) 2022-10-25
IL294120A (en) 2022-08-01
KR20220128644A (ko) 2022-09-21
JP2023514327A (ja) 2023-04-05
WO2021183771A1 (en) 2021-09-16

Similar Documents

Publication Publication Date Title
BR112019006388A2 (pt) enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas
BR112022012350A2 (pt) Nucleases de spcas9 de alta fidelidade para modificação de genoma
BR112022014837A2 (pt) Vacinas de rna contra coronavírus
BR122021025194A8 (pt) Molécula de ácido nucleico, método para obter rna, rna, método para obter um peptídeo ou proteína e usos in vitro ou ex vivo do rna
WO2018191278A3 (en) Targeted compositions
BR112015012375A2 (pt) modificação e regulação de genoma à base de crispr
BR112018011711A2 (pt) peptídeos de direcionamento para direcionar virus adeno-associados (aav)
BR112022007125A2 (pt) Variantes de nucleases cas12a e métodos de produção e uso das mesmas
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
BR112014003919A2 (pt) métodos e meios para modificar um genoma de planta
CL2021000028A1 (es) Anticuerpo multiespecifico (divisional de solicitud 937-2020).
BRPI0819526B8 (pt) Sequência de ácido nucleico de precursor de mirna artificial, construção recombinante e método para reduzir a expressão de uma sequência alvo
BR112016005228A8 (pt) Uso de uma ou mais glicosidases e processo para produzir um oligossacarídeo
BR112022013236A2 (pt) Anticorpos anti-cd73 e usos dos mesmos
AR115041A1 (es) Meganucleasas optimizadas diseñadas mediante ingeniería que poseen especificidad para una secuencia de reconocimiento en el genoma del virus de la hepatitis b
WO2022221359A8 (en) Epstein-barr virus mrna vaccines
MX2021006745A (es) Constructos de iarn modificados quimicamente y usos de estos.
BR112021000202A8 (pt) Síntese enzimática de análogos de nucleosídeo 4'-etinila
BR112012018385A2 (pt) indução e estabilização de atividade enzimática em micro-organismos
BR112018008062A2 (pt) micro-organismos do gênero corynebacterium que têm capacidade de produção de l- isoleucina e métodos para produzir l-isoleucina com o uso dos mesmos
EA202190454A1 (ru) Новый crispr-ассоциированный белок и его применение
BR112022024501A2 (pt) Construtos de rnai para inibir a expressão de hsd17b13 e métodos de uso dos mesmos
BR112021024080A2 (pt) Construtos de rnai para inibir a expressão de scap e métodos de uso dos mesmos
BR112023015937A2 (pt) Compostos, composições e métodos de uso dos mesmos
MY182519A (en) Method for producing lipid using acyl-acp thioesterase